The Future of Medicine Series is an informal moderated forum bringing together research professionals and clinicians interested in drug development.

Each session has a 30-minute presentation and a 45-minute moderated discussion. For more information on this series or to register for a specific event please contact MaRS at events@marsdd.com.

Speaker: Colin Vicente, MSc. Managing Director, PIVINA Consulting

Abstract:

The biotechnology and pharmaceutical industry is confronting significant short-term and long-term challenges. One of which is the ever increasing financial pressures placed on them through governmental and provincial processes both in Canada and abroad.  These pose quickly evolving challenges; however, the overriding issue remains the need for effective market access strategies to gain better and faster commercialization.  This seminar focuses on health economic, reimbursement and pricing policies implemented by governments and discussion of best practices adopted by companies with a proven track record in gaining patient access to their products.

About the Speaker

Colin Vicente has spent the last decade designing and implementing health economic studies, executing on price optimization plans and delivering results through successful reimbursement strategies in the Pharmaceutical and Biopharmaceutical markets.

As part Owner and Managing Director of PIVINA Consulting Inc., an innovative consulting and research company, his focus is on producing impactful results in the areas of:

• Health Economics and Outcomes Research
• Reimbursement Submission Dossiers
• Payer Negotiations

He is also a Professor of Pharmacoeconomics at Seneca College and tutorial leader in Pharmacoeconomics at the University of Toronto, Faculty of Pharmacy.

Colin holds an MSc in Health Economics from the University of Toronto, Faculty of Pharmacy and Honours Toxicology Degree from the University of Toronto, Faculty of Life Sciences.

Generously supported by: